$UUUU
ENERGY FUELS INC Stock $uuuu

$uuuu Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000138584924000048 Filed on August 02, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$4.047M	$8.719M
YoY Change	-63.17%	27.04%
Cost Of Revenue	$1.847M	$3.681M
YoY Change	-66.71%	-15.71%
Gross Profit	$2.200M	$5.038M
YoY Change	-59.55%	101.84%
Gross Profit Margin	54.36%	57.78%
Selling, General & Admin	$7.060M	$7.083M
YoY Change	-3.34%	-5.03%
% of Gross Profit	320.91%	140.59%
Research & Development		$1.867M
YoY Change		-51.13%
% of Gross Profit		37.06%
Depreciation & Amortization	$660.0K	$620.0K
YoY Change	-4.35%	-6.06%
% of Gross Profit	30.0%	12.31%
Operating Expenses	$7.060M	$7.083M
YoY Change	-3.34%	-5.03%
Operating Profit	-$11.91M	-$9.044M
YoY Change	71.56%	-15.18%
Interest Expense		$2.623M
YoY Change		-13.15%
% of Operating Profit
Other Income/Expense, Net	-$166.0K	$2.625M
YoY Change	-100.95%	-54.57%
Pretax Income		-$6.419M
YoY Change		31.27%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$12.08M	-$6.420M
YoY Change	-215.38%	31.42%
Net Earnings / Revenue	-298.49%	-73.63%
Basic Earnings Per Share	-$0.07	-$0.04
Diluted Earnings Per Share	-$0.07	-$0.04
COMMON SHARES
Basic Shares Outstanding	163.7M shares	163.7M shares
Diluted Shares Outstanding	163.9M shares	163.7M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$171.2M
YoY Change		71.76%
Cash & Equivalents	$47.46M	$24.59M
Short-Term Investments		$146.7M
Other Short-Term Assets		$3.985M
YoY Change		-7.33%
Inventory	$35.91M	$30.41M
Prepaid Expenses	$4.490M	$3.985M
Receivables		$9.021M
Other Receivables		$527.0K
Total Short-Term Assets	$193.9M	$208.3M
YoY Change	14.9%	48.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$43.55M	$40.36M
YoY Change	115.5%	131.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$9.306M	$3.473M
YoY Change	-64.34%	-80.04%
Other Assets		$24.81M
YoY Change		26.59%
Total Long-Term Assets	$206.5M	$195.1M
YoY Change	-11.16%	-15.96%
TOTAL ASSETS
Total Short-Term Assets	$193.9M	$208.3M
Total Long-Term Assets	$206.5M	$195.1M
Total Assets	$400.4M	$403.4M
YoY Change	-0.2%	8.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.706M	$2.246M
YoY Change	161.54%	41.7%
Accrued Expenses		$5.119M
YoY Change		27.98%
Deferred Revenue	$600.0K
YoY Change	80.72%
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$10.77M	$7.365M
YoY Change	71.63%	32.25%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$13.29M
YoY Change		16.61%
Total Long-Term Liabilities		$13.29M
YoY Change		16.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.77M	$7.365M
Total Long-Term Liabilities		$13.29M
Total Liabilities	$23.72M	$20.66M
YoY Change	32.75%	22.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$371.1M	-$359.0M
YoY Change	10.4%	3.55%
Common Stock	$745.8M	$739.8M
YoY Change	3.93%	5.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$372.7M	$378.8M
YoY Change
Total Liabilities & Shareholders Equity	$400.4M	$403.4M
YoY Change	-0.2%	8.42%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$12.08M	-$6.420M
YoY Change	-215.38%	31.42%
Depreciation, Depletion And Amortization	$660.0K	$620.0K
YoY Change	-4.35%	-6.06%
Cash From Operating Activities		-$9.675M
YoY Change		601.09%
INVESTING ACTIVITIES
Capital Expenditures		$13.79M
YoY Change		127.48%
Acquisitions
YoY Change
Other Investing Activities		-$6.346M
YoY Change		1713.14%
Cash From Investing Activities		-$20.13M
YoY Change		214.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		53.00K
YoY Change		-110.0%
NET CHANGE
Cash From Operating Activities		-9.675M
Cash From Investing Activities		-20.13M
Cash From Financing Activities		53.00K
Net Change In Cash		-29.75M
YoY Change		257.61%
FREE CASH FLOW
Cash From Operating Activities		-$9.675M
Capital Expenditures		$13.79M
Free Cash Flow		-$23.46M
YoY Change		215.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.69
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4885000	usd
	us-gaap	Net Income Loss NetIncomeLoss	109379000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.69
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-6418000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-4861000	usd
	us-gaap	Profit Loss ProfitLoss	-2779000	usd
	us-gaap	Profit Loss ProfitLoss	109404000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	24000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	25000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-6419000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4885000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2781000	usd
	us-gaap	Net Income Loss NetIncomeLoss	109379000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24594000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	57445000	usd
CY2024Q2	efr	Marketable Securities Debt And Equity Fvni MarketableSecuritiesDebtAndEquityFVNI	146655000	usd
CY2023Q4	efr	Marketable Securities Debt And Equity Fvni MarketableSecuritiesDebtAndEquityFVNI	133044000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	223000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	223000	usd
CY2024Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	9548000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	816000	usd
CY2024Q2	efr	Inventory Current InventoryCurrent	23524000	usd
CY2023Q4	efr	Inventory Current InventoryCurrent	38868000	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3985000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2522000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	208306000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	232695000	usd
CY2024Q2	us-gaap	Mineral Properties Net MineralPropertiesNet	123840000	usd
CY2023Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	119581000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40356000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26123000	usd
CY2024Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	6887000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1852000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1127000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1219000	usd
CY2024Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	3473000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1356000	usd
CY2024Q2	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	1482000	usd
CY2023Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	1534000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	17924000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	17579000	usd
CY2024Q2	us-gaap	Assets Assets	403395000	usd
CY2023Q4	us-gaap	Assets Assets	401939000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7147000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10161000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	218000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	199000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7365000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10360000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1006000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1120000	usd
CY2024Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	11688000	usd
CY2023Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	10922000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	600000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	332000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	20659000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	22734000	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	163661111	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	163661111	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	162659155	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	162659155	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	739762000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	733450000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-359037000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-356258000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1946000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1946000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	378779000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	375246000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	3957000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	3959000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	382736000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	379205000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	403395000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	401939000	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	379205000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3638000	usd
CY2024Q1	efr	Shares Issued For Cash By At The Market Offering SharesIssuedForCashByAtTheMarketOffering	4898000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	110000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1345000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	552000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	103000	usd
CY2024Q1	efr	Stock Issued During Period Value Cash Paymentfor Tax Withholding StockIssuedDuringPeriodValueCashPaymentforTaxWithholding	837000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	387690000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-6419000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1412000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	53000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	382736000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	244409000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	114264000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1186000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	72000	usd
CY2023Q1	efr	Stock Issued During Period Value Cash Paymentfor Tax Withholding StockIssuedDuringPeriodValueCashPaymentforTaxWithholding	918000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	359013000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4885000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1554000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	312000	usd
CY2023Q2	efr	Stock Issued During Period Value Cash Paymentfor Tax Withholding StockIssuedDuringPeriodValueCashPaymentforTaxWithholding	848000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	355146000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2781000	usd
	us-gaap	Net Income Loss NetIncomeLoss	109379000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1858000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1319000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2757000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2740000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	589000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	620000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-353000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	325000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2189000	usd
	efr	Debt Securities Fvni Gain Loss DebtSecuritiesFVNIGainLoss	861000	usd
	efr	Debt Securities Fvni Gain Loss DebtSecuritiesFVNIGainLoss	0	usd
	efr	Gain On Disposal Of Non Core Assets GainOnDisposalOfNonCoreAssets	2000	usd
	efr	Gain On Disposal Of Non Core Assets GainOnDisposalOfNonCoreAssets	119257000	usd
	efr	Miscellaneous Non Cash Income Expenses MiscellaneousNonCashIncomeExpenses	-27000	usd
	efr	Miscellaneous Non Cash Income Expenses MiscellaneousNonCashIncomeExpenses	76000	usd
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	985000	usd
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	335000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10788000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5515000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	8754000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	2373000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1442000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1348000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2327000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2269000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-834000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4069000	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	16307000	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	5467000	usd
	efr	Purchase Of Mineral Properties PurchaseOfMineralProperties	4737000	usd
	efr	Purchase Of Mineral Properties PurchaseOfMineralProperties	3055000	usd
	efr	Acquisition Of Mineral Properties AcquisitionOfMineralProperties	0	usd
	efr	Acquisition Of Mineral Properties AcquisitionOfMineralProperties	22374000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	145017000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	67775000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	133253000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	16405000	usd
	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	2149000	usd
	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	0	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	56859000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-34955000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25407000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4788000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	156000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	384000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3555000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1382000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-272000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50000	usd
	efr	Release Of Restricted Cash ReleaseOfRestrictedCash	0	usd
	efr	Release Of Restricted Cash ReleaseOfRestrictedCash	-3590000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-32506000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-27218000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	75024000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80269000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42518000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53051000	usd
	us-gaap	Interest Paid Net InterestPaidNet	96000	usd
	us-gaap	Interest Paid Net InterestPaidNet	13000	usd
	efr	Increase Decrease In Accrued Capital Expenditures And Accounts Payable For Property Plant And Equipment IncreaseDecreaseInAccruedCapitalExpendituresAndAccountsPayableForPropertyPlantAndEquipment	-415000	usd
	efr	Increase Decrease In Accrued Capital Expenditures And Accounts Payable For Property Plant And Equipment IncreaseDecreaseInAccruedCapitalExpendituresAndAccountsPayableForPropertyPlantAndEquipment	734000	usd
	efr	Noncash Acquisition Of Convertible Note NoncashAcquisitionOfConvertibleNote	0	usd
	efr	Noncash Acquisition Of Convertible Note NoncashAcquisitionOfConvertibleNote	59259000	usd
CY2024Q2	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	2150000	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	28159000	usd
CY2024Q2	efr	Equity Securities Fvni Gross Unrealized Loss EquitySecuritiesFVNIGrossUnrealizedLoss	2280000	usd
CY2024Q2	efr	Equity Securities Fvni Gross Unrealized Gain EquitySecuritiesFVNIGrossUnrealizedGain	0	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	25879000	usd
CY2024Q2	efr	Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Cost DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNICost	147575000	usd
CY2024Q2	efr	Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax	2280000	usd
CY2024Q2	efr	Total Marketable Securities TotalMarketableSecurities	1360000	usd
CY2024Q2	efr	Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNI	146655000	usd
CY2023Q4	efr	Debt Securities Fvni Cost DebtSecuritiesFVNICost	106791000	usd
CY2023Q4	efr	Debt Securities Fvni Gross Unrealized Loss DebtSecuritiesFVNIGrossUnrealizedLoss	0	usd
CY2023Q4	efr	Debt Securities Fvni Gross Unrealized Gain DebtSecuritiesFVNIGrossUnrealizedGain	675000	usd
CY2023Q4	efr	Debt Securities Fvni DebtSecuritiesFVNI	107466000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	28159000	usd
CY2023Q4	efr	Equity Securities Fvni Gross Unrealized Loss EquitySecuritiesFVNIGrossUnrealizedLoss	2581000	usd
CY2023Q4	efr	Equity Securities Fvni Gross Unrealized Gain EquitySecuritiesFVNIGrossUnrealizedGain	0	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	25578000	usd
CY2023Q4	efr	Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Cost DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNICost	134950000	usd
CY2023Q4	efr	Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax	2581000	usd
CY2023Q4	efr	Total Marketable Securities TotalMarketableSecurities	675000	usd
CY2023Q4	efr	Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNI	133044000	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	19636000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	35807000	usd
CY2024Q2	efr	Inventory Of Ore In Stockpiles InventoryOfOreInStockpiles	9137000	usd
CY2023Q4	efr	Inventory Of Ore In Stockpiles InventoryOfOreInStockpiles	3072000	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1638000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1841000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	30411000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	40720000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	78278000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	62048000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	37922000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	35925000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40356000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26123000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	620000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	660000	usd
	us-gaap	Depreciation Depreciation	1290000	usd
	us-gaap	Depreciation Depreciation	1320000	usd
CY2024Q2	us-gaap	Mineral Properties Gross MineralPropertiesGross	124407000	usd
CY2023Q2	us-gaap	Mineral Properties Gross MineralPropertiesGross	119581000	usd
CY2024Q2	us-gaap	Mineral Properties Accumulated Depletion MineralPropertiesAccumulatedDepletion	567000	usd
CY2023Q2	us-gaap	Mineral Properties Accumulated Depletion MineralPropertiesAccumulatedDepletion	0	usd
CY2024Q2	us-gaap	Mineral Properties Net MineralPropertiesNet	123840000	usd
CY2023Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	119581000	usd
CY2023Q1	efr	Number Of Purchase Agreements NumberOfPurchaseAgreements	2	purchaseagreement
CY2023Q1	efr	Number Of Mineral Concessions Acquired NumberOfMineralConcessionsAcquired	17	mineral_concession
CY2023Q1	efr	Purchase Agreement Acres To Purchase PurchaseAgreementAcresToPurchase	37300	acre
CY2023Q1	efr	Purchase Agreement Miles To Purchase PurchaseAgreementMilesToPurchase	58.3	mi
CY2023Q1	efr	Number Of Mineral Concessions Acquired NumberOfMineralConcessionsAcquired	17	mineral_concession
CY2023Q1	efr	Purchase Agreement Purchase Price PurchaseAgreementPurchasePrice	27500000	usd
CY2023Q1	efr	Purchase Agreement Deposit Payment PurchaseAgreementDepositPayment	5900000	usd
CY2023Q1	efr	Purchase Agreement Payment Due At Closing PurchaseAgreementPaymentDueAtClosing	21600000	usd
CY2023Q1	efr	Purchase Agreement Direct Deal Costs PurchaseAgreementDirectDealCosts	1630000	usd
CY2023Q2	efr	Restricted Cash And Cash Equivalents Held For Sale RestrictedCashAndCashEquivalentsHeldForSale	3590000	usd
CY2023Q2	efr	Restricted Cash And Cash Equivalents Held For Sale RestrictedCashAndCashEquivalentsHeldForSale	3590000	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	10922000	usd
	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	177000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	589000	usd
CY2024Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	11688000	usd
	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	180000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	17579000	usd
	efr	Additional Collateral Posted AdditionalCollateralPosted	345000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	17924000	usd
CY2024Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	0	shares
CY2023Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	0	shares
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6418000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4861000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2779000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	109404000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163655888	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	158137420	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163533507	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	158034370	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1156936	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	163655888	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	158137420	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	163533507	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	159191306	shares
CY2024Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.04
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.02
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.69
CY2024Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.04
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.03
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.02
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.69
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1670000	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1500000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1580000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	310000	shares
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1412000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1554000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2757000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2740000	usd
	efr	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisable Period SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePeriod	P5Y
CY2024Q1	us-gaap	Share Price SharePrice	7.48
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	523468	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.48
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	583546	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.74
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	46382	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.37
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	19959	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.40
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	2291	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	5.75
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1038382	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.31
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y2M8D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	896000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	402325	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.09
	efr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term Instant SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermInstant	P1Y7M9D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	892000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-6420000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4890000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2780000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Net Income Loss NetIncomeLoss	109380000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2024Q2	efr	Change In Value Of Investments Accounted At Fair Value ChangeInValueOfInvestmentsAccountedAtFairValue	0	usd
CY2023Q2	efr	Change In Value Of Investments Accounted At Fair Value ChangeInValueOfInvestmentsAccountedAtFairValue	770000	usd
	efr	Change In Value Of Investments Accounted At Fair Value ChangeInValueOfInvestmentsAccountedAtFairValue	0	usd
	efr	Change In Value Of Investments Accounted At Fair Value ChangeInValueOfInvestmentsAccountedAtFairValue	-2189000	usd
CY2024Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	445000	usd
CY2023Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	10000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	985000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	335000	usd
CY2024Q2	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	649000	usd
CY2023Q2	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	214000	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	861000	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	214000	usd
CY2024Q2	efr	Debt Securities Convertible Note Unrealized Gain Loss DebtSecuritiesConvertibleNoteUnrealizedGainLoss	0	usd
CY2023Q2	efr	Debt Securities Convertible Note Unrealized Gain Loss DebtSecuritiesConvertibleNoteUnrealizedGainLoss	-53000	usd
	efr	Debt Securities Convertible Note Unrealized Gain Loss DebtSecuritiesConvertibleNoteUnrealizedGainLoss	0	usd
	efr	Debt Securities Convertible Note Unrealized Gain Loss DebtSecuritiesConvertibleNoteUnrealizedGainLoss	-251000	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	349000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	293000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-353000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	319000	usd
CY2024Q2	efr	Component Of Other Income Expense ComponentOfOtherIncomeExpense	1180000	usd
CY2023Q2	efr	Component Of Other Income Expense ComponentOfOtherIncomeExpense	1737000	usd
	efr	Component Of Other Income Expense ComponentOfOtherIncomeExpense	2747000	usd
	efr	Component Of Other Income Expense ComponentOfOtherIncomeExpense	2762000	usd
CY2024Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2623000	usd
CY2023Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2971000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	4240000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1190000	usd
CY2024Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	9021000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	406000	usd
CY2024Q2	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	343000	usd
CY2023Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	343000	usd
CY2024Q2	efr	Accounts And Other Receivables Net AccountsAndOtherReceivablesNet	184000	usd
CY2023Q4	efr	Accounts And Other Receivables Net AccountsAndOtherReceivablesNet	67000	usd
CY2024Q2	efr	Receivables Net ReceivablesNet	9548000	usd
CY2023Q4	efr	Receivables Net ReceivablesNet	816000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2246000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1006000	usd
CY2024Q2	efr	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	2350000	usd
CY2023Q4	efr	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	4391000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2134000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4162000	usd
CY2024Q2	efr	Accrued Capital Expenditures Current AccruedCapitalExpendituresCurrent	11000	usd
CY2023Q4	efr	Accrued Capital Expenditures Current AccruedCapitalExpendituresCurrent	205000	usd
CY2024Q2	efr	Accrued Property Taxes Current AccruedPropertyTaxesCurrent	382000	usd
CY2023Q4	efr	Accrued Property Taxes Current AccruedPropertyTaxesCurrent	393000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	24000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7147000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10161000	usd
CY2023Q4	efr	Convertible Note Receivable Redeemed ConvertibleNoteReceivableRedeemed	40000000	usd
CY2023Q4	efr	Convertible Notes Receivable Sold ConvertibleNotesReceivableSold	20000000	usd
CY2023Q4	efr	Convertible Note Receivable Consideration Received ConvertibleNoteReceivableConsiderationReceived	21000000	usd
CY2023Q4	efr	Convertible Note Receivable Unpaid Accrued Interest ConvertibleNoteReceivableUnpaidAccruedInterest	1500000	usd
CY2023Q4	efr	Convertible Note Receivable Sales Commission ConvertibleNoteReceivableSalesCommission	100000	usd
CY2023Q4	efr	Proceeds From Convertible Note Receivable ProceedsFromConvertibleNoteReceivable	22400000	usd
CY2024Q2	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	164413000	usd
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	173556000	usd
CY2023Q2	efr	Change In Value Of Investments Accounted At Fair Value ChangeInValueOfInvestmentsAccountedAtFairValue	770000	usd
CY2024Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	9020000.00	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	410000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001385849-24-000048-index-headers.html	Edgar Link	pending
0001385849-24-000048-index.html	Edgar Link	pending
0001385849-24-000048.txt	Edgar Link	pending
0001385849-24-000048-xbrl.zip	Edgar Link	pending
efr-20240630_def.xml	Edgar Link	unprocessable
efr-20240630_cal.xml	Edgar Link	unprocessable
efr-20240630.htm	Edgar Link	pending
efr-20240630.xsd	Edgar Link	pending
efr-20240630_g1.jpg	Edgar Link	pending
efr06302024-exx231.htm	Edgar Link	pending
efr06302024-exx311.htm	Edgar Link	pending
efr06302024-exx312.htm	Edgar Link	pending
efr06302024-exx321.htm	Edgar Link	pending
efr06302024-exx322.htm	Edgar Link	pending
efr06302024-exx951.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
efr-20240630_lab.xml	Edgar Link	unprocessable
efr-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
efr-20240630_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UUUU
ENERGY FUELS INC Stock $uuuu

2024 Q3 Form 10-Q Financial Statement

#000138584924000048 Filed on August 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UUUU ENERGY FUELS INC Stock $uuuu

2024 Q3 Form 10-Q Financial Statement

#000138584924000048 Filed on August 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UUUU
ENERGY FUELS INC Stock $uuuu